The human umbilical cord (UC) and placenta are non-invasive, primitive and abundant
sources of mesenchymal stromal cells (MSCs) that have increasingly gained attention …

Mesenchymal stem/stromal cells (MSCs) derived from placental tissue show great
therapeutic potential and have been used in medical treatment, but the similarity and …

Mesenchymal stem cells (MSC) could potentially be applied in therapeutic settings due to
their multilineage differentiation ability, immunomodulatory properties, as well as their …

Background Mesenchymal stromal cells (MSC) have been identified in a variety of fetal and
adult tissues, including bone marrow (BM), fetal blood and liver. We report on the isolation …

Mesenchymal stromal cells (MSCs) are rare progenitor cells that can be isolated from
various tissues. They exhibit multilineage differentiation potential, support regenerative …

Mesenchymal stem/stromal cells (MSCs) are currently one of the most extensively
researched fields due to their promising opportunity for use in regenerative medicine. There …

Umbilical cord derived mesenchymal stromal cells (UC‐MSCs) are a focus for clinical
translation but standardized methods for isolation and expansion are lacking. Previously we …

Background Studies in which mesenchymal stromal cells (MSC) from the placenta are
compared with multiple MSC types from other sources are rare. The chorionic plate of the …

Background Multipotent mesenchymal stromal cells (MSC) are of interest for their potential
to repair bone and cartilage, and also their immunosuppressive properties. Umbilical cord …

Mesenchymal stem/stromal cells (MSC) are promising candidates for use in cell-based
therapies. In most cases, therapeutic response appears to be cell-dose dependent. Human …